The Claim
Sodium bicarbonate therapy in critically ill patients with metabolic acidosis has no significant effect on 28-day mortality, 90-day mortality, ICU length of stay, or organ failure rates.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Giving sodium bicarbonate to critically ill patients with metabolic acidosis does not reduce their risk of dying within 28 or 90 days, shorten their stay in the intensive care unit, or lower the rate of organ failure.
See the scientific wording
In critically ill patients with metabolic acidosis, sodium bicarbonate therapy has no significant effect on 28-day or 90-day mortality, ICU length of stay, or organ failure rates, suggesting that correcting acidosis alone does not improve survival in this population.
When the body is severely ill, tissues don't get enough blood and oxygen, causing cells to produce excess acid. This acid builds up in the blood, but it doesn't kill the patient — it just shows how badly the tissues are damaged. Giving bicarbonate to neutralize the acid doesn't fix the underlying problem of poor blood flow or cell failure, so the patient doesn't live longer or recover faster.
What the research says
1 studyGiving baking soda to very sick patients with acidosis doesn’t help them live longer, stay less time in the ICU, or have fewer failing organs — even though it might reduce the need for dialysis or infections. So acidosis is probably just a sign of how sick they already are, not something that kills them directly.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.